Search Results 421-430 of 9698 for Sulfasalazine

  1. A Study To Evaluate The Effects Of Oral Levosimendan (ODM-109) On Respiratory Function In Patients With ALS - Mayo Clinic

    The purpose of this study is to evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in ...

  2. Daratumumab and hyaluronidase-fihj (subcutaneous route) - Side effects & uses - Mayo Clinic

    Daratumumab and hyaluronidase-fihj combination injection is used together with bortezomib, lenalidomide, and dexamethasone to treat newly diagnosed multiple ...

  3. Alglucosidase alfa (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Alglucosidase alfa injection is an enzyme used to treat Pompe disease (glycogen storage disease type II), including infantile-onset Pompe ...

  4. Gastroenterology and Hepatology - Clinical trials

    This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary ...

  5. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

    A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety ...

  6. Cholestyramine (oral route) - Side effects & dosage - Mayo Clinic

    This may help prevent medical problems caused by cholesterol clogging the blood vessels. Cholestyramine is also used to remove substances called bile acids from ...

  7. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

    Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  8. Myositis Interstitial Lung Disease Nintedanib Trial - Mayo Clinic

    ... Sulfasalazine (max dose 3 gm/day) IVIG (Intravenous immunoglobulin) or SQIG (subcutaneous immunoglobulin) (max dose 2 gm/kg/month). Rituximab is allowed if ...

  9. Clinical trials - Oncology (Medical)

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  10. Pralsetinib (oral route) - Side effects & dosage - Mayo Clinic

    Pralsetinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) and in patients whose tumors have RET fusion- ...